Abstract
Inflammatory bowel diseases (IBD) are idiopathic and may be evidenced by chronic inflammation of the gastrointestinal tract. Usually, the indicated therapies for IBD are based on the administration of sulfasalazine, corticosteroid, immunomodulator, and biological therapy. However, new therapeutic strategies involving the inflammatory process are being proposed. Studies have highlighted th…